Souders Financial Advisors Edwards Lifesciences Corp Transaction History

Souders Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$61.71 - $77.76 $9,997 - $12,597	162 Added 2.42%	6,853 $522,000
Q3 2023 Nov 06, 2023	BUY	$69.28 - $93.38 $969 - $1,307	14 Added 0.21%	6,691 $463,000
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $6,594 - $7,640	81 Added 1.23%	6,677 $629,000
Q1 2023 May 09, 2023	BUY	$74.26 - $84.51 $3,638 - $4,140	49 Added 0.75%	6,596 $545,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $67,890 - $86,915	994 Added 17.9%	6,547 $488,000
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $41,843 - $54,503	-508 Reduced 8.38%	5,553 $459,000
Q2 2022 Aug 05, 2022	BUY	$86.5 - $128.27 $2,162 - $3,206	25 Added 0.41%	6,061 $576,000
Q1 2022 May 04, 2022	BUY	$101.96 - $128.34 $12,541 - $15,785	123 Added 2.08%	6,036 $711,000
Q4 2021 Feb 04, 2022	BUY	$106.37 - $130.68 $12,232 - $15,028	115 Added 1.98%	5,913 $766,000
Q3 2021 Nov 03, 2021	BUY	$102.91 - $122.75 $596,672 - $711,704	5,798 New	5,798 $656,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Souders Financial Advisors with notifications on news.